|
| Exchange Received Time 01/08/2018 11:20:46 Exchange Disseminated Time 01/08/2018 11:20:49 Time Taken 00:00:03 | Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, please be informed that the Company's API manufacturing facility at Pithampur, Madhya Pradesh was inspected by US FDA from July 23rd to July 27th, 2018. Four observations were made which do not impact continuity of the Company's business and its manufacturing activity. The Company proposes to respond to these observations within 15 business days.
The Pithampur facility manufactures API for use in the production of formulations that are exported to the USA.
|
|
|